Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_provenance.
- NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_assertion wasGeneratedBy ECO_0000203 NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_provenance.
- NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_assertion wasDerivedFrom befree-20150227 NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_provenance.
- NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_assertion SIO_000772 23110092 NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_provenance.
- NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_assertion evidence source_evidence_literature NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_provenance.
- NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_assertion description "[Treatment of WM3211 or metastatic melanoma cell lines with anti-cancer agents (including vemurafenib) induced expression of UGT2B7, UGT2B10 and UGT2B15 demonstrating that melanoma cells retain the ability to re-express these same three UGTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766402.RAb1i-pVAKRC4k3dE3eA4LD_loH2qKYshKK3nEOVhsUHA130_provenance.